Methods: In an analysis of Delaware Hospital Discharge Database we identified Delaware and non-Delaware residents discharged with AMI or asthma for the years 1999-2004. Data analysis compared the incidence of AMI or asthma before (1999-2002) and after (2003-2004) the amendment of Delaware's non-smoking ordinance for each group.
Results: Pre-ordinance and post-ordinance quarterly rates of AMI for Delaware residents were 451 (se = 21) and 430 (se = 21) respectively, representing a 4.7% reduction and 169 fewer AMI over the two-year period after implementation of the comprehensive smoke-free ordinance (2003-2004). The risk ratio (RR) for post vs. pre-ordinance quarterly rate of AMI showed a statistically significant decrease of 0.95 (95% CI, 0.91 to 0.99; P=0.022) and a population adjusted RR of 0.91 (95% CI, 0.87 to 0.95; P<0.001). Over the same time period, there was negligible change in the incidence of AMI for non-Delaware residents. After adjusting for population growth, the RR for asthma in Delaware residents post-ordinance was 0.95 (95% CI, 0.90 to 0.997), a significant reduction (P=0.038). By comparison, non-Delaware residents had an increased RR for asthma post-ordinance of 1.62 (95% CI, 1.46 to 1.86; P<0.0001).
Conclusions: Delaware's comprehensive non-smoking ordinance led to a statistically significant decrease in the incidence of AMI and asthma in Delaware residents but not in non-Delaware residents.
Learning Objectives:
Determine the correlation between comprehensive non-smoking ordinances and incidence rates of AMI and asthma.
Compare the level of AMI and asthma between Delaware residents and non-Delaware residents before (1999-2002) and after (2003-2004) the amendment of Delaware’s non-smoking ordinance.
Describe the effects of the pre and post non-smoking ordinances to the rates of incidence of AMI and asthma.
Keywords: Tobacco Policy, Smoking
Qualified on the content I am responsible for because: Primary investigator
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Alcohol, Tobacco, and Other Drugs
![[ Visit Client Website ]](images/banner.gif)